Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects
Clinical trial NCT02795039 · COMPLETED
Trial details
- NCT number
- NCT02795039
- Sponsor
- Fresenius Kabi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-03-03
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.